Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Endoscope Makers: Remove Steris Sterilizing System From Labeling

This article was originally published in The Gray Sheet

Executive Summary

Endoscope makers who currently instruct users to clean the devices with Steris' System 1 liquid chemical sterilization system may have to file for additional FDA approval or clearance after relabeling their products to reflect an alternative reprocessing method, the agency says
Advertisement

Related Content

FDA Reprocessing Guidance Aims To Reduce Hospital Infections
FDA Reprocessing Guidance Aims To Reduce Hospital Infections
Technology Hazards Remain High, But Industry Can Help, ECRI Exec Says
Technology Hazards Remain High, But Industry Can Help, ECRI Exec Says
Steris Agrees To Consent Order With FDA To Resolve Sterilizer Problems
Steris Agrees To Consent Order With FDA To Resolve Sterilizer Problems
Regulatory News In Brief
Steris Defends Sterilizer System, Awaits Further FDA Action
Steris Defends Sterilizer System, Awaits Further FDA Action
Regulatory News In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT028552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel